<?xml version="1.0" encoding="UTF-8"?>
<JDBOR date="2025-12-09 07:19:03" version="1.3.42 / 4.1.8 [2025-03-03]" copyright="Orphanet (c) 2025" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
  <ResearchProjectList count="1">
    <ResearchProject id="169417">
      <ExpertLink lang="en">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=698983</ExpertLink>
      <Name_en>APPOLON: Optimization of the best drug candidate derived from natriuretic peptides to disperse Pseudomonas aeruginosa biofilm and in vivo validation</Name_en>
      <ResearchProjectTypeFlagList count="2">
        <ResearchProjectTypeFlag id="26949">
          <Value>1048576</Value>
          <Name lang="en">Biotechnology innovation</Name>
        </ResearchProjectTypeFlag>
        <ResearchProjectTypeFlag id="14946">
          <Value>1</Value>
          <Name lang="en">Research project</Name>
        </ResearchProjectTypeFlag>
      </ResearchProjectTypeFlagList>
      <ResearchProjectStatusFlagList count="2">
        <ResearchProjectStatusFlag id="35">
          <Value>1</Value>
          <Name lang="en">on-line</Name>
        </ResearchProjectStatusFlag>
        <ResearchProjectStatusFlag id="463">
          <Value>262144</Value>
          <Name lang="en">IRDiRC</Name>
        </ResearchProjectStatusFlag>
      </ResearchProjectStatusFlagList>
      <Url>https://anr.fr//projet-ANR-23-CE17-0005</Url>
      <ProtocolUrl>https://storage.orphanet.app/RCH/FR/bdfa9feae60e0e50bdf0a9c23eaea3665d46cb00.pdf</ProtocolUrl>
      <PSOIEUrl>https://storage.orphanet.app/RCH/FR/bdfa9feae60e0e50bdf0a9c23eaea3665d46cb00.pdf</PSOIEUrl>
      <Country id="75">
        <Name lang="en">FRANCE</Name>
      </Country>
      <DrugTradeNameResearchProjectAssociationList count="0">
      </DrugTradeNameResearchProjectAssociationList>
      <SubstanceResearchProjectAssociationList count="0">
      </SubstanceResearchProjectAssociationList>
      <ValidationDate>2025-04-29 00:00:00.0</ValidationDate>
      <InstitutionList count="1">
        <Institution id="42630">
          <Status id="13">
            <Name lang="en">Public</Name>
          </Status>
        </Institution>
      </InstitutionList>
      <PersonActivityAssociationList count="0">
        <PersonActivityAssociation>
          <PersonFunction id="5">
            <Type>Rch</Type>
            <Name lang="en">Investigator of research project</Name>
          </PersonFunction>
          <Institution id="42630">
            <Department_Service_Lab_PatientOrganisationAcronym/>
            <Department_Service_Lab_PatientOrganisationName>Pôle Europe et International</Department_Service_Lab_PatientOrganisationName>
            <UpperLevelOfAffiliationAcronym/>
            <UpperLevelOfAffiliation>Univeristé de Rouen Normandie</UpperLevelOfAffiliation>
            <Address id="25598">
              <Town>
                <Name>MONT-SAINT-AIGNAN</Name>
              </Town>
              <Country id="75">
                <Name lang="en">FRANCE</Name>
              </Country>
            </Address>
          </Institution>
        </PersonActivityAssociation>
        <PersonActivityAssociation>
          <PersonFunction id="43">
            <Type>Rch</Type>
            <Name lang="en">Public funding body</Name>
          </PersonFunction>
        </PersonActivityAssociation>
      </PersonActivityAssociationList>
      <DisorderList count="1">
        <Disorder id="49">
          <OrphaCode>586</OrphaCode>
          <Name lang="en">Cystic fibrosis</Name>
        </Disorder>
      </DisorderList>
      <GeneList count="0">
      </GeneList>
    </ResearchProject>
  </ResearchProjectList>
</JDBOR>
